
This is an old revision of the document!
Table of Contents
Northern Lincolnshire and Goole NHS Foundation Trust - Nuclear Medicine
When this document is not viewed in the Nuclear Medicine Wiki, the reader is responsible for checking that it is the most current version. This can be checked at nlag.heynm.org.uk
SOP Code | Title | Review Date |
---|---|---|
REF024 | Gastro-Intestinal Bleeding | 2027-12-24 |
Authorised By | Authorisation Signature (only on master paper copy) | Date Authorised |
---|---|---|
Prof G Avery | 2021-04-19 |
REF024 - Gastro-Intestinal Bleeding Scintigraphy
Purpose
The purpose of this document is to assist clinicians in deciding on the appropriateness of the Nuclear Medicine procedure and to give guidance on the mechanism of referral.
Background
The localisation of gastrointestinal bleeding is usually with endoscopy or radiographic procedures - CT or catheter angiography. In problematic cases, however, the use of technetium-99m labelled red blood cells may contribute to the management of a patient who is actively bleeding.
A site of active bleeding is localised by an accumulation of labelled red blood cells in the abdomen and the general configuration of radiopharmaceutical in the gut lumen can give some localisation. This can also assist in the choice of mesenteric vessel to catheterise first if angiography is to be performed afterwards.
A red blood cell study can be positive at bleeding rates of 0.5 ml per minute. In some cases, bleeding rates as low as 0.1 ml per minute may be detected. The study should be performed rapidly after bleeding is detected.
There is often a problem with the timing of this investigation, either because the bleeding is intermittent or because a patient admitted to hospital with a gastrointestinal haemorrhage is stabilised before examination by which time the bleeding has stopped.
ARSAC Licence Holders |
---|
Prof Ged Avery |
Dr Najeeb Ahmed |
Nuclide | Pharmaceutical Form | Local DRL (MBq) |
---|---|---|
Tc99m | Pertechnetate (after inactive stannous agent/PYP) | 400 |
Typical Radiation Dose (mSv) | 2.8mSv for 400MBq |
---|
Staff Permitted to Refer
The referrer may be any clinician holding a current valid medical qualification and currently employed in Secondary Care.
Referring clinicians are reminded of the requirement to avoid unnecessary exposure to ionising radiation. The investigation may already have been requested at this hospital or elsewhere and clinicians are asked to be particularly vigilant to ensure that their request is not a double request.
Acceptance of Referrals
Requests will only be accepted if the diagnostic question fulfills one of the referral criteria below. Appropriate clinical information must be supplied to allow the investigation to be justified. It is not acceptable to simply request the investigation without appropriate clinical information.
Requests will be returned to the referrer if:
- The diagnostic question is unclear.
- The diagnostic question cannot be answered by the investigation.
- Insufficient clinical information is supplied to justify the investigation.
Requests should be submitted on the orange stripe NUCLEAR MEDICINE (ISOTOPE SCAN) request form. Patient details, Investigation required and Reason for Test/Diagnostic Question should be fully and appropriately completed and the form signed.
Note the requirement for Patient Preparation below
Referral Criteria
Sufficient clinical information must be provided to justify the investigation proceeding.
Investigation |
---|
Localisation of a site of active gastrointestinal bleeding |
Contraindications
Patient Demographics | Pregnancy |
---|
Patient Preparation
- If the patient is haemodynamically unstable they will need to be monitored by a doctor or nurse when in the department[1]. Please note that the nuclear medicine department do not have staff who can monitor such patients.
- Breast feeding patients will need to stop breast feeding for 20 hours following this procedure and should consider expressing milk in advance of the procedure to be used for feeding during this period.